Adolescent polycystic ovary syndrome according to the international evidence-based guideline

Background Diagnosing polycystic ovary syndrome (PCOS) during adolescence is challenging because features of normal pubertal development overlap with adult diagnostic criteria. The international evidence-based PCOS Guideline aimed to promote accurate and timely diagnosis, to optimise consistent care...

Full description

Saved in:
Bibliographic Details
Published inBMC medicine Vol. 18; no. 1; pp. 72 - 16
Main Authors Peña, Alexia S., Witchel, Selma F., Hoeger, Kathleen M., Oberfield, Sharon E., Vogiatzi, Maria G., Misso, Marie, Garad, Rhonda, Dabadghao, Preeti, Teede, Helena
Format Journal Article
LanguageEnglish
Published London BioMed Central 24.03.2020
BioMed Central Ltd
BMC
Subjects
Acne
Adolescence
Adolescents
Age
Amenorrhea
Antidiabetics
Biomedicine
Child development
Consumers
Contraceptives
Criteria
Demographic aspects
Depression (Mood disorder)
Diagnosis
Diagnostic systems
Eating disorders
Endocrinology
Evaluation
Evidence-based
Evidence-based medicine
Experts
Girls
Guideline
Gynecology
Health care reform
Health services
Hirsutism
Hormones
Infertility
Medical diagnosis
Medical personnel
Medicine
Medicine & Public Health
Menarche
Menstrual cycle
Menstruation
Metformin
Physiology
Polycystic ovary syndrome
Practice guidelines (Medicine)
Puberty
Quality
Retirement benefits
Symptom management
Teenagers
Treatment
Ultrasound
Womens health
Youth
Australia
Polycystic ovary syndrome
Treatment
Evidence-based
Diagnosis
Adolescents
Girls
Online AccessGet full text
ISSN1741-7015
1741-7015
DOI10.1186/s12916-020-01516-x

Cover

Abstract Background Diagnosing polycystic ovary syndrome (PCOS) during adolescence is challenging because features of normal pubertal development overlap with adult diagnostic criteria. The international evidence-based PCOS Guideline aimed to promote accurate and timely diagnosis, to optimise consistent care, and to improve health outcomes for adolescents and women with PCOS. Methods International healthcare professionals, evidence synthesis teams and consumers informed the priorities, reviewed published data and synthesised the recommendations for the Guideline. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework was applied to appraise the evidence quality and the feasibility, acceptability, cost, implementation and strength of the recommendations. Results This paper focuses on the specific adolescent PCOS Guideline recommendations. Specific criteria to improve diagnostic accuracy and avoid over diagnosis include: (1) irregular menstrual cycles defined according to years post-menarche; > 90 days for any one cycle (> 1 year post-menarche), cycles< 21 or > 45 days (> 1 to < 3 years post-menarche); cycles < 21 or > 35 days (> 3 years post-menarche) and primary amenorrhea by age 15 or > 3 years post-thelarche. Irregular menstrual cycles (< 1 year post-menarche) represent normal pubertal transition. (2) Hyperandrogenism defined as hirsutism, severe acne and/or biochemical hyperandrogenaemia confirmed using validated high-quality assays. (3) Pelvic ultrasound not recommended for diagnosis of PCOS within 8 years post menarche. (4) Anti-Müllerian hormone levels not recommended for PCOS diagnosis; and (5) exclusion of other disorders that mimic PCOS. For adolescents who have features of PCOS but do not meet diagnostic criteria an ‘at risk’ label can be considered with appropriate symptomatic treatment and regular re-evaluations. Menstrual cycle re-evaluation can occur over 3 years post menarche and where only menstrual irregularity or hyperandrogenism are present initially, evaluation with ultrasound can occur after 8 years post menarche. Screening for anxiety and depression is required and assessment of eating disorders warrants consideration. Available data endorse the benefits of healthy lifestyle interventions to prevent excess weight gain and should be recommended. For symptom management, the combined oral contraceptive pill and/or metformin may be beneficial. Conclusions Extensive international engagement accompanied by rigorous processes honed both diagnostic criteria and treatment recommendations for PCOS during adolescence.
AbstractList Abstract Background Diagnosing polycystic ovary syndrome (PCOS) during adolescence is challenging because features of normal pubertal development overlap with adult diagnostic criteria. The international evidence-based PCOS Guideline aimed to promote accurate and timely diagnosis, to optimise consistent care, and to improve health outcomes for adolescents and women with PCOS. Methods International healthcare professionals, evidence synthesis teams and consumers informed the priorities, reviewed published data and synthesised the recommendations for the Guideline. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework was applied to appraise the evidence quality and the feasibility, acceptability, cost, implementation and strength of the recommendations. Results This paper focuses on the specific adolescent PCOS Guideline recommendations. Specific criteria to improve diagnostic accuracy and avoid over diagnosis include: (1) irregular menstrual cycles defined according to years post-menarche; > 90 days for any one cycle (> 1 year post-menarche), cycles< 21 or > 45 days (> 1 to < 3 years post-menarche); cycles < 21 or > 35 days (> 3 years post-menarche) and primary amenorrhea by age 15 or > 3 years post-thelarche. Irregular menstrual cycles (< 1 year post-menarche) represent normal pubertal transition. (2) Hyperandrogenism defined as hirsutism, severe acne and/or biochemical hyperandrogenaemia confirmed using validated high-quality assays. (3) Pelvic ultrasound not recommended for diagnosis of PCOS within 8 years post menarche. (4) Anti-Müllerian hormone levels not recommended for PCOS diagnosis; and (5) exclusion of other disorders that mimic PCOS. For adolescents who have features of PCOS but do not meet diagnostic criteria an ‘at risk’ label can be considered with appropriate symptomatic treatment and regular re-evaluations. Menstrual cycle re-evaluation can occur over 3 years post menarche and where only menstrual irregularity or hyperandrogenism are present initially, evaluation with ultrasound can occur after 8 years post menarche. Screening for anxiety and depression is required and assessment of eating disorders warrants consideration. Available data endorse the benefits of healthy lifestyle interventions to prevent excess weight gain and should be recommended. For symptom management, the combined oral contraceptive pill and/or metformin may be beneficial. Conclusions Extensive international engagement accompanied by rigorous processes honed both diagnostic criteria and treatment recommendations for PCOS during adolescence.
Background Diagnosing polycystic ovary syndrome (PCOS) during adolescence is challenging because features of normal pubertal development overlap with adult diagnostic criteria. The international evidence-based PCOS Guideline aimed to promote accurate and timely diagnosis, to optimise consistent care, and to improve health outcomes for adolescents and women with PCOS. Methods International healthcare professionals, evidence synthesis teams and consumers informed the priorities, reviewed published data and synthesised the recommendations for the Guideline. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework was applied to appraise the evidence quality and the feasibility, acceptability, cost, implementation and strength of the recommendations. Results This paper focuses on the specific adolescent PCOS Guideline recommendations. Specific criteria to improve diagnostic accuracy and avoid over diagnosis include: (1) irregular menstrual cycles defined according to years post-menarche; > 90 days for any one cycle (> 1 year post-menarche), cycles< 21 or > 45 days (> 1 to < 3 years post-menarche); cycles < 21 or > 35 days (> 3 years post-menarche) and primary amenorrhea by age 15 or > 3 years post-thelarche. Irregular menstrual cycles (< 1 year post-menarche) represent normal pubertal transition. (2) Hyperandrogenism defined as hirsutism, severe acne and/or biochemical hyperandrogenaemia confirmed using validated high-quality assays. (3) Pelvic ultrasound not recommended for diagnosis of PCOS within 8 years post menarche. (4) Anti-Müllerian hormone levels not recommended for PCOS diagnosis; and (5) exclusion of other disorders that mimic PCOS. For adolescents who have features of PCOS but do not meet diagnostic criteria an ‘at risk’ label can be considered with appropriate symptomatic treatment and regular re-evaluations. Menstrual cycle re-evaluation can occur over 3 years post menarche and where only menstrual irregularity or hyperandrogenism are present initially, evaluation with ultrasound can occur after 8 years post menarche. Screening for anxiety and depression is required and assessment of eating disorders warrants consideration. Available data endorse the benefits of healthy lifestyle interventions to prevent excess weight gain and should be recommended. For symptom management, the combined oral contraceptive pill and/or metformin may be beneficial. Conclusions Extensive international engagement accompanied by rigorous processes honed both diagnostic criteria and treatment recommendations for PCOS during adolescence.
Diagnosing polycystic ovary syndrome (PCOS) during adolescence is challenging because features of normal pubertal development overlap with adult diagnostic criteria. The international evidence-based PCOS Guideline aimed to promote accurate and timely diagnosis, to optimise consistent care, and to improve health outcomes for adolescents and women with PCOS.BACKGROUNDDiagnosing polycystic ovary syndrome (PCOS) during adolescence is challenging because features of normal pubertal development overlap with adult diagnostic criteria. The international evidence-based PCOS Guideline aimed to promote accurate and timely diagnosis, to optimise consistent care, and to improve health outcomes for adolescents and women with PCOS.International healthcare professionals, evidence synthesis teams and consumers informed the priorities, reviewed published data and synthesised the recommendations for the Guideline. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework was applied to appraise the evidence quality and the feasibility, acceptability, cost, implementation and strength of the recommendations.METHODSInternational healthcare professionals, evidence synthesis teams and consumers informed the priorities, reviewed published data and synthesised the recommendations for the Guideline. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework was applied to appraise the evidence quality and the feasibility, acceptability, cost, implementation and strength of the recommendations.This paper focuses on the specific adolescent PCOS Guideline recommendations. Specific criteria to improve diagnostic accuracy and avoid over diagnosis include: (1) irregular menstrual cycles defined according to years post-menarche; > 90 days for any one cycle (> 1 year post-menarche), cycles< 21 or > 45 days (> 1 to < 3 years post-menarche); cycles < 21 or > 35 days (> 3 years post-menarche) and primary amenorrhea by age 15 or > 3 years post-thelarche. Irregular menstrual cycles (< 1 year post-menarche) represent normal pubertal transition. (2) Hyperandrogenism defined as hirsutism, severe acne and/or biochemical hyperandrogenaemia confirmed using validated high-quality assays. (3) Pelvic ultrasound not recommended for diagnosis of PCOS within 8 years post menarche. (4) Anti-Müllerian hormone levels not recommended for PCOS diagnosis; and (5) exclusion of other disorders that mimic PCOS. For adolescents who have features of PCOS but do not meet diagnostic criteria an 'at risk' label can be considered with appropriate symptomatic treatment and regular re-evaluations. Menstrual cycle re-evaluation can occur over 3 years post menarche and where only menstrual irregularity or hyperandrogenism are present initially, evaluation with ultrasound can occur after 8 years post menarche. Screening for anxiety and depression is required and assessment of eating disorders warrants consideration. Available data endorse the benefits of healthy lifestyle interventions to prevent excess weight gain and should be recommended. For symptom management, the combined oral contraceptive pill and/or metformin may be beneficial.RESULTSThis paper focuses on the specific adolescent PCOS Guideline recommendations. Specific criteria to improve diagnostic accuracy and avoid over diagnosis include: (1) irregular menstrual cycles defined according to years post-menarche; > 90 days for any one cycle (> 1 year post-menarche), cycles< 21 or > 45 days (> 1 to < 3 years post-menarche); cycles < 21 or > 35 days (> 3 years post-menarche) and primary amenorrhea by age 15 or > 3 years post-thelarche. Irregular menstrual cycles (< 1 year post-menarche) represent normal pubertal transition. (2) Hyperandrogenism defined as hirsutism, severe acne and/or biochemical hyperandrogenaemia confirmed using validated high-quality assays. (3) Pelvic ultrasound not recommended for diagnosis of PCOS within 8 years post menarche. (4) Anti-Müllerian hormone levels not recommended for PCOS diagnosis; and (5) exclusion of other disorders that mimic PCOS. For adolescents who have features of PCOS but do not meet diagnostic criteria an 'at risk' label can be considered with appropriate symptomatic treatment and regular re-evaluations. Menstrual cycle re-evaluation can occur over 3 years post menarche and where only menstrual irregularity or hyperandrogenism are present initially, evaluation with ultrasound can occur after 8 years post menarche. Screening for anxiety and depression is required and assessment of eating disorders warrants consideration. Available data endorse the benefits of healthy lifestyle interventions to prevent excess weight gain and should be recommended. For symptom management, the combined oral contraceptive pill and/or metformin may be beneficial.Extensive international engagement accompanied by rigorous processes honed both diagnostic criteria and treatment recommendations for PCOS during adolescence.CONCLUSIONSExtensive international engagement accompanied by rigorous processes honed both diagnostic criteria and treatment recommendations for PCOS during adolescence.
Background Diagnosing polycystic ovary syndrome (PCOS) during adolescence is challenging because features of normal pubertal development overlap with adult diagnostic criteria. The international evidence-based PCOS Guideline aimed to promote accurate and timely diagnosis, to optimise consistent care, and to improve health outcomes for adolescents and women with PCOS. Methods International healthcare professionals, evidence synthesis teams and consumers informed the priorities, reviewed published data and synthesised the recommendations for the Guideline. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework was applied to appraise the evidence quality and the feasibility, acceptability, cost, implementation and strength of the recommendations. Results This paper focuses on the specific adolescent PCOS Guideline recommendations. Specific criteria to improve diagnostic accuracy and avoid over diagnosis include: (1) irregular menstrual cycles defined according to years post-menarche; > 90 days for any one cycle (> 1 year post-menarche), cycles< 21 or > 45 days (> 1 to < 3 years post-menarche); cycles < 21 or > 35 days (> 3 years post-menarche) and primary amenorrhea by age 15 or > 3 years post-thelarche. Irregular menstrual cycles (< 1 year post-menarche) represent normal pubertal transition. (2) Hyperandrogenism defined as hirsutism, severe acne and/or biochemical hyperandrogenaemia confirmed using validated high-quality assays. (3) Pelvic ultrasound not recommended for diagnosis of PCOS within 8 years post menarche. (4) Anti-Müllerian hormone levels not recommended for PCOS diagnosis; and (5) exclusion of other disorders that mimic PCOS. For adolescents who have features of PCOS but do not meet diagnostic criteria an ‘at risk’ label can be considered with appropriate symptomatic treatment and regular re-evaluations. Menstrual cycle re-evaluation can occur over 3 years post menarche and where only menstrual irregularity or hyperandrogenism are present initially, evaluation with ultrasound can occur after 8 years post menarche. Screening for anxiety and depression is required and assessment of eating disorders warrants consideration. Available data endorse the benefits of healthy lifestyle interventions to prevent excess weight gain and should be recommended. For symptom management, the combined oral contraceptive pill and/or metformin may be beneficial. Conclusions Extensive international engagement accompanied by rigorous processes honed both diagnostic criteria and treatment recommendations for PCOS during adolescence.
Diagnosing polycystic ovary syndrome (PCOS) during adolescence is challenging because features of normal pubertal development overlap with adult diagnostic criteria. The international evidence-based PCOS Guideline aimed to promote accurate and timely diagnosis, to optimise consistent care, and to improve health outcomes for adolescents and women with PCOS. International healthcare professionals, evidence synthesis teams and consumers informed the priorities, reviewed published data and synthesised the recommendations for the Guideline. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework was applied to appraise the evidence quality and the feasibility, acceptability, cost, implementation and strength of the recommendations. This paper focuses on the specific adolescent PCOS Guideline recommendations. Specific criteria to improve diagnostic accuracy and avoid over diagnosis include: (1) irregular menstrual cycles defined according to years post-menarche; > 90 days for any one cycle (> 1 year post-menarche), cycles< 21 or > 45 days (> 1 to < 3 years post-menarche); cycles < 21 or > 35 days (> 3 years post-menarche) and primary amenorrhea by age 15 or > 3 years post-thelarche. Irregular menstrual cycles (< 1 year post-menarche) represent normal pubertal transition. (2) Hyperandrogenism defined as hirsutism, severe acne and/or biochemical hyperandrogenaemia confirmed using validated high-quality assays. (3) Pelvic ultrasound not recommended for diagnosis of PCOS within 8 years post menarche. (4) Anti-Müllerian hormone levels not recommended for PCOS diagnosis; and (5) exclusion of other disorders that mimic PCOS. For adolescents who have features of PCOS but do not meet diagnostic criteria an 'at risk' label can be considered with appropriate symptomatic treatment and regular re-evaluations. Menstrual cycle re-evaluation can occur over 3 years post menarche and where only menstrual irregularity or hyperandrogenism are present initially, evaluation with ultrasound can occur after 8 years post menarche. Screening for anxiety and depression is required and assessment of eating disorders warrants consideration. Available data endorse the benefits of healthy lifestyle interventions to prevent excess weight gain and should be recommended. For symptom management, the combined oral contraceptive pill and/or metformin may be beneficial. Extensive international engagement accompanied by rigorous processes honed both diagnostic criteria and treatment recommendations for PCOS during adolescence.
Background Diagnosing polycystic ovary syndrome (PCOS) during adolescence is challenging because features of normal pubertal development overlap with adult diagnostic criteria. The international evidence-based PCOS Guideline aimed to promote accurate and timely diagnosis, to optimise consistent care, and to improve health outcomes for adolescents and women with PCOS. Methods International healthcare professionals, evidence synthesis teams and consumers informed the priorities, reviewed published data and synthesised the recommendations for the Guideline. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework was applied to appraise the evidence quality and the feasibility, acceptability, cost, implementation and strength of the recommendations. Results This paper focuses on the specific adolescent PCOS Guideline recommendations. Specific criteria to improve diagnostic accuracy and avoid over diagnosis include: (1) irregular menstrual cycles defined according to years post-menarche; > 90 days for any one cycle (> 1 year post-menarche), cycles< 21 or > 45 days (> 1 to < 3 years post-menarche); cycles < 21 or > 35 days (> 3 years post-menarche) and primary amenorrhea by age 15 or > 3 years post-thelarche. Irregular menstrual cycles (< 1 year post-menarche) represent normal pubertal transition. (2) Hyperandrogenism defined as hirsutism, severe acne and/or biochemical hyperandrogenaemia confirmed using validated high-quality assays. (3) Pelvic ultrasound not recommended for diagnosis of PCOS within 8 years post menarche. (4) Anti-Müllerian hormone levels not recommended for PCOS diagnosis; and (5) exclusion of other disorders that mimic PCOS. For adolescents who have features of PCOS but do not meet diagnostic criteria an 'at risk' label can be considered with appropriate symptomatic treatment and regular re-evaluations. Menstrual cycle re-evaluation can occur over 3 years post menarche and where only menstrual irregularity or hyperandrogenism are present initially, evaluation with ultrasound can occur after 8 years post menarche. Screening for anxiety and depression is required and assessment of eating disorders warrants consideration. Available data endorse the benefits of healthy lifestyle interventions to prevent excess weight gain and should be recommended. For symptom management, the combined oral contraceptive pill and/or metformin may be beneficial. Conclusions Extensive international engagement accompanied by rigorous processes honed both diagnostic criteria and treatment recommendations for PCOS during adolescence. Keywords: Adolescents, Girls, Polycystic ovary syndrome, Evidence-based, Diagnosis, Treatment
Diagnosing polycystic ovary syndrome (PCOS) during adolescence is challenging because features of normal pubertal development overlap with adult diagnostic criteria. The international evidence-based PCOS Guideline aimed to promote accurate and timely diagnosis, to optimise consistent care, and to improve health outcomes for adolescents and women with PCOS. International healthcare professionals, evidence synthesis teams and consumers informed the priorities, reviewed published data and synthesised the recommendations for the Guideline. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework was applied to appraise the evidence quality and the feasibility, acceptability, cost, implementation and strength of the recommendations. This paper focuses on the specific adolescent PCOS Guideline recommendations. Specific criteria to improve diagnostic accuracy and avoid over diagnosis include: (1) irregular menstrual cycles defined according to years post-menarche; > 90 days for any one cycle (> 1 year post-menarche), cycles< 21 or > 45 days (> 1 to < 3 years post-menarche); cycles < 21 or > 35 days (> 3 years post-menarche) and primary amenorrhea by age 15 or > 3 years post-thelarche. Irregular menstrual cycles (< 1 year post-menarche) represent normal pubertal transition. (2) Hyperandrogenism defined as hirsutism, severe acne and/or biochemical hyperandrogenaemia confirmed using validated high-quality assays. (3) Pelvic ultrasound not recommended for diagnosis of PCOS within 8 years post menarche. (4) Anti-Müllerian hormone levels not recommended for PCOS diagnosis; and (5) exclusion of other disorders that mimic PCOS. For adolescents who have features of PCOS but do not meet diagnostic criteria an 'at risk' label can be considered with appropriate symptomatic treatment and regular re-evaluations. Menstrual cycle re-evaluation can occur over 3 years post menarche and where only menstrual irregularity or hyperandrogenism are present initially, evaluation with ultrasound can occur after 8 years post menarche. Screening for anxiety and depression is required and assessment of eating disorders warrants consideration. Available data endorse the benefits of healthy lifestyle interventions to prevent excess weight gain and should be recommended. For symptom management, the combined oral contraceptive pill and/or metformin may be beneficial. Extensive international engagement accompanied by rigorous processes honed both diagnostic criteria and treatment recommendations for PCOS during adolescence.
ArticleNumber 72
Audience Academic
Author Misso, Marie
Garad, Rhonda
Dabadghao, Preeti
Witchel, Selma F.
Vogiatzi, Maria G.
Hoeger, Kathleen M.
Oberfield, Sharon E.
Peña, Alexia S.
Teede, Helena
Author_xml – sequence: 1
  givenname: Alexia S.
  orcidid: 0000-0002-6834-4876
  surname: Peña
  fullname: Peña, Alexia S.
  email: alexia.pena@adelaide.edu.au
  organization: Discipline of Paediatrics, The University of Adelaide Robinson Research Institute and Endocrine Department, Women’s and Children’s Hospital
– sequence: 2
  givenname: Selma F.
  surname: Witchel
  fullname: Witchel, Selma F.
  organization: Department of Pediatrics, Division of Pediatric Endocrinology, UPMC Children’s Hospital of Pittsburgh, University of Pittsburgh
– sequence: 3
  givenname: Kathleen M.
  surname: Hoeger
  fullname: Hoeger, Kathleen M.
  organization: Department of OBGYN, University of Rochester Medical Center
– sequence: 4
  givenname: Sharon E.
  surname: Oberfield
  fullname: Oberfield, Sharon E.
  organization: Division of Pediatric Endocrinology, Columbia University Irving Medical Center
– sequence: 5
  givenname: Maria G.
  surname: Vogiatzi
  fullname: Vogiatzi, Maria G.
  organization: Division of Endocrinology, Children’s Hospital of Philadelphia, Perelman School of Medicine at the University of Philadelphia
– sequence: 6
  givenname: Marie
  surname: Misso
  fullname: Misso, Marie
  organization: Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University and Monash Health
– sequence: 7
  givenname: Rhonda
  surname: Garad
  fullname: Garad, Rhonda
  organization: Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University and Monash Health
– sequence: 8
  givenname: Preeti
  surname: Dabadghao
  fullname: Dabadghao, Preeti
  organization: Department of Endocrinology, Sanjay Gandhi Postgraduate Institute of Medical Sciences
– sequence: 9
  givenname: Helena
  surname: Teede
  fullname: Teede, Helena
  organization: Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University and Monash Health
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32204714$$D View this record in MEDLINE/PubMed
BookMark eNp9UstqGzEUHUpK82h_oIsyUAjdTCppHpI2BRPaJhDopt0VhF4zlpElV5ox8d_32k4TO5SghXSlc450j855cRJisEXxHqMrjFn3OWPCcVchgiqEW1jdvyrOMG1wRaE-OVifFuc5LxAiLaXNm-K0JgQ1FDdnxe-Zid5mbcNYrqLf6E0enS7jWqZNmTfBpLi0pdQ6JuPCUI6xHOe2dGG0KcjRxSB9adfO2KBtpWS2phwmKL0L9m3xupc-23cP80Xx69vXn9c31d2P77fXs7tKU9SMlWItsw3HlGHDNG64aWpWk1pJaRDmlCKKFEItR1rbGvNeYdW0irBe1gQbXl8Ut3tdE-VCrJJbwutFlE7sNmIahEzQlrdCctz0iHctVbKpbQe6vVKq70C2N10PWl_2WqtJLa3ZGpOkPxI9PgluLoa4FhRxAk2AwKcHgRT_TDaPYunAX-9lsHHKgtSMdIwxxAD68Rl0ESew1W9RHH4X8fYANUhowIU-wr16KypmHWYUfKEIUFf_QcEwduk0BKd3sH9EuDwgzK304zxHP23_NB8DPxw68mjFvxABgOwBOsWck-0fIRiJbVLFPqkCkip2SRX3QGLPSNqNu0DBu51_mVrvqRnuCYNNT7a9wPoLjK_8YA
CitedBy_id crossref_primary_10_1016_j_neubiorev_2023_105147
crossref_primary_10_1016_j_endmts_2024_100159
crossref_primary_10_1016_j_endinu_2021_10_013
crossref_primary_10_1210_jendso_bvaa166
crossref_primary_10_7759_cureus_11343
crossref_primary_10_54393_pbmj_v4i2_159
crossref_primary_10_1210_clinem_dgae426
crossref_primary_10_30841_2708_8731_1_2022_258133
crossref_primary_10_1016_j_fertnstert_2021_05_094
crossref_primary_10_3390_children9111748
crossref_primary_10_1007_s11102_022_01250_y
crossref_primary_10_1007_s12445_022_1444_8
crossref_primary_10_1038_s41598_022_26274_z
crossref_primary_10_2147_DMSO_S365829
crossref_primary_10_1016_j_psyneuen_2020_105104
crossref_primary_10_4103_jfmpc_jfmpc_2360_21
crossref_primary_10_1016_j_eswa_2023_120102
crossref_primary_10_1016_S2213_8587_22_00163_2
crossref_primary_10_1111_jpc_15097
crossref_primary_10_1590_1806_9282_20200890
crossref_primary_10_1093_humrep_deab101
crossref_primary_10_1093_humrep_deae050
crossref_primary_10_3389_fpsyt_2022_984653
crossref_primary_10_1093_humrep_deaa371
crossref_primary_10_1007_s13312_023_3066_z
crossref_primary_10_37989_gumussagbil_1003117
crossref_primary_10_1155_2022_7933166
crossref_primary_10_1210_jendso_bvaa177
crossref_primary_10_17116_klinderma20232201184
crossref_primary_10_1111_cen_14578
crossref_primary_10_1210_jcemcr_luae083
crossref_primary_10_30841_2708_8731_2_2022_261816
crossref_primary_10_1297_cpe_2022_0010
crossref_primary_10_1186_s13048_025_01634_1
crossref_primary_10_12956_tchd_1347807
crossref_primary_10_1097_MED_0000000000000881
crossref_primary_10_1097_MOP_0000000000001255
crossref_primary_10_1210_clinem_dgab385
crossref_primary_10_3390_cells12010174
crossref_primary_10_1001_jama_2024_11809
crossref_primary_10_1210_clinem_dgae771
crossref_primary_10_1055_s_0042_1742292
crossref_primary_10_1177_09593535211030748
crossref_primary_10_4103_ijem_ijem_379_23
crossref_primary_10_1016_j_jadohealth_2024_06_021
crossref_primary_10_7759_cureus_25340
crossref_primary_10_1016_j_eprac_2021_08_005
crossref_primary_10_1016_j_endien_2021_10_012
crossref_primary_10_1055_s_0042_1757138
crossref_primary_10_1002_rmb2_12615
crossref_primary_10_1016_j_coemr_2020_04_007
crossref_primary_10_1016_j_jtcme_2022_08_003
crossref_primary_10_1055_s_0041_1742259
crossref_primary_10_1016_j_jpag_2020_08_015
crossref_primary_10_1007_s00431_023_04875_8
crossref_primary_10_1016_j_jpag_2024_06_007
crossref_primary_10_5694_mja2_52432
crossref_primary_10_11648_j_jgo_20241204_12
crossref_primary_10_3928_19382359_20210622_01
crossref_primary_10_1007_s12553_021_00613_y
crossref_primary_10_1016_j_jpag_2021_03_001
crossref_primary_10_1093_ejendo_lvae125
crossref_primary_10_2196_65469
crossref_primary_10_1186_s12902_025_01899_z
crossref_primary_10_1093_humrep_deac252
crossref_primary_10_1155_2022_7238344
crossref_primary_10_1515_jpem_2022_0249
crossref_primary_10_1159_000531264
crossref_primary_10_22141_2224_0551_17_5_2022_1520
crossref_primary_10_1007_s40618_023_02210_4
crossref_primary_10_2196_46718
crossref_primary_10_1007_s13224_024_01994_6
crossref_primary_10_1016_j_jpag_2020_06_017
crossref_primary_10_1515_jpem_2023_0232
crossref_primary_10_1007_s13679_020_00388_9
crossref_primary_10_3389_fpsyt_2022_937280
crossref_primary_10_52711_2349_2996_2022_00030
crossref_primary_10_1016_j_molmed_2023_02_006
crossref_primary_10_4103_jehp_jehp_15_21
crossref_primary_10_1111_cen_15163
crossref_primary_10_1007_s12098_023_04678_7
crossref_primary_10_1016_S1634_7358_24_49206_1
crossref_primary_10_1097_MOP_0000000000000928
crossref_primary_10_1111_pedi_13409
crossref_primary_10_1016_S2352_4642_24_00019_1
crossref_primary_10_1016_j_ogc_2024_08_005
crossref_primary_10_1177_17455057221117966
crossref_primary_10_14341_probl12874
crossref_primary_10_4103_ijph_ijph_1508_22
crossref_primary_10_3934_medsci_2021026
crossref_primary_10_3390_diagnostics12081931
crossref_primary_10_1210_clinem_dgae462
crossref_primary_10_3390_nu14010073
crossref_primary_10_1016_j_ajog_2024_11_010
crossref_primary_10_1007_s12020_021_02955_z
crossref_primary_10_1016_j_amepre_2024_12_016
crossref_primary_10_1093_humrep_deac197
crossref_primary_10_1186_s12884_021_03808_3
crossref_primary_10_1093_ejendo_lvad055
crossref_primary_10_1177_08465371231185292
crossref_primary_10_1016_j_endmts_2025_100228
crossref_primary_10_1080_17446651_2022_2099839
crossref_primary_10_36106_ijsr_8601441
crossref_primary_10_1159_000529183
crossref_primary_10_1007_s40619_024_01432_9
crossref_primary_10_1016_j_jadohealth_2024_11_015
crossref_primary_10_3390_app15052772
crossref_primary_10_26442_20795696_2023_1_201761
crossref_primary_10_3389_fphar_2022_1065243
crossref_primary_10_3390_jcm12031221
crossref_primary_10_1093_humupd_dmad027
crossref_primary_10_1016_j_coemr_2020_07_004
crossref_primary_10_1089_jwh_2023_0741
crossref_primary_10_3390_children11050521
crossref_primary_10_1042_BSR20211658
crossref_primary_10_3389_fendo_2022_1072879
crossref_primary_10_3389_fpubh_2024_1454415
crossref_primary_10_2147_IJWH_S506498
crossref_primary_10_1210_jendso_bvab060
crossref_primary_10_1007_s41969_023_00211_5
crossref_primary_10_1093_humrep_deae262
crossref_primary_10_1007_s11042_024_19707_6
crossref_primary_10_1016_j_bpobgyn_2023_102400
crossref_primary_10_2174_1573404818666220329123334
crossref_primary_10_32628_IJSRST218665
crossref_primary_10_1097_01_JAA_0000791468_37054_5d
crossref_primary_10_1159_000539697
crossref_primary_10_1111_cen_14604
crossref_primary_10_3389_fphys_2022_887077
crossref_primary_10_1159_000526616
crossref_primary_10_2174_1389557523666230608124651
crossref_primary_10_31083_j_ceog5105126
crossref_primary_10_32604_csse_2023_037812
crossref_primary_10_1016_j_xinn_2023_100407
crossref_primary_10_3390_children10121905
crossref_primary_10_1080_09513590_2024_2352139
crossref_primary_10_1089_whr_2024_0116
crossref_primary_10_1080_13625187_2020_1795118
crossref_primary_10_1159_000543033
crossref_primary_10_1007_s00404_020_05867_x
crossref_primary_10_3390_diagnostics13061113
crossref_primary_10_1210_clinem_dgaa839
crossref_primary_10_1136_bmjgast_2020_000574
crossref_primary_10_1016_j_jpag_2024_02_004
crossref_primary_10_1515_jpem_2021_0487
crossref_primary_10_46563_1560_9561_2024_27_1_55_60
crossref_primary_10_1016_S1636_5410_24_49087_9
crossref_primary_10_3390_nu15143144
crossref_primary_10_1007_s12519_024_00857_4
crossref_primary_10_1186_s12905_024_03455_8
crossref_primary_10_1038_s41572_024_00511_3
crossref_primary_10_1007_s00403_024_03466_3
crossref_primary_10_1136_gocm_2024_000115
crossref_primary_10_1186_s13063_023_07593_6
crossref_primary_10_3390_children10121872
crossref_primary_10_23736_S2724_5276_21_06542_3
crossref_primary_10_1001_jamanetworkopen_2021_47454
crossref_primary_10_1186_s12916_025_03901_w
crossref_primary_10_1111_jog_15975
Cites_doi 10.1016/S0015-0282(01)01701-0
10.1016/S0015-0282(16)58146-1
10.1515/CCLM.2007.031
10.1111/jpc.13821
10.1016/j.psyneuen.2016.08.005
10.1016/j.fertnstert.2008.06.035
10.1542/peds.2015-4089
10.1136/archdischild-2017-312968
10.1016/j.fertnstert.2013.12.056
10.1093/humupd/dmp024
10.1016/j.fertnstert.2013.04.001
10.1016/j.tem.2019.04.006
10.1080/01443615.2017.1318840
10.1093/humrep/deh079
10.1542/peds.2013-0490B
10.1210/jcem-57-1-82
10.1111/j.1365-2648.2009.05061.x
10.1210/jc.2013-2385
10.1016/j.jpag.2012.03.004
10.1210/jc.2003-031281
10.3109/09513590.2015.1025380
10.4274/jcrpe.3253
10.1007/s11920-017-0834-2
10.1186/1472-6874-13-51
10.1210/jc.2015-3543
10.1210/jc.2003-031780
10.1093/humupd/dmm030
10.1367/A04-130R.1
10.1016/j.fertnstert.2003.10.004
10.1093/humrep/der197
10.1016/j.jpag.2008.01.081
10.1067/mpd.2001.109790
10.1093/humrep/13.8.2252
10.3109/09513590.2013.777415
10.1016/j.jpag.2012.06.008
10.1002/jcu.20723
10.1097/AOG.0b013e318202b0a4
10.1210/jc.2012-3537
10.1542/peds.2006-2481
10.1080/03014468400007411
10.1007/s40519-018-0533-y
10.1111/cen.14013
10.1210/jc.2013-1393
10.2214/ajr.178.6.1781531
10.1210/jc.2009-1908
10.1016/j.fertnstert.2004.02.118
10.1016/j.jpag.2013.03.007
10.1055/s-0038-1667155
10.1371/journal.pone.0071465
10.1515/JPEM.2005.18.8.761
10.1097/AOG.0b013e31823f7135
10.1210/jc.2007-2437
10.1210/jc.2009-2631
10.1016/S0029-7844(02)01660-5
10.1016/j.jadohealth.2016.10.015
10.1016/j.fertnstert.2009.11.002
10.1111/j.1365-2125.2011.04063.x
10.1159/000479371
10.1210/jc.2014-3886
10.1210/jc.2005-2250
10.1111/ajr.12288
10.1016/j.fertnstert.2006.11.039
10.1016/j.fertnstert.2010.06.015
10.1111/j.1365-2362.2011.02550.x
10.1210/er.2010-0013
10.1016/j.ejogrb.2014.05.006
10.1210/jc.2004-2283
10.1016/j.fertnstert.2011.06.040
10.1210/jc.2008-0461
10.1016/S2213-8587(19)30345-6
10.1210/jcem-45-5-1039
10.1530/eje.0.1450619
10.1210/jcem-54-2-241
10.1093/humrep/14.9.2223
10.1093/humupd/dms029
10.1016/j.jpag.2013.09.010
10.1111/j.1365-2265.2012.04475.x
10.1530/eje.0.1410361
10.1016/j.jpag.2018.01.007
10.4274/tjod.21549
10.1111/j.1467-789X.2012.01053.x
10.1210/jc.2004-2301
10.1016/j.mefs.2014.10.003
10.1093/humrep/dew218
10.1093/humrep/dey256
10.1093/humrep/dex044
10.1210/jcem-21-11-1440
10.1210/jc.2013-2350
10.1016/S1701-2163(16)34499-1
10.1159/000375530
10.1503/cmaj.090449
10.1093/hropen/hoz011
10.1016/S0022-3476(97)70307-X
10.1093/humrep/deq273
10.1016/j.fertnstert.2011.10.022
10.1093/humrep/der102
10.1053/ybeog.2002.0342
10.1002/jcu.20522
10.1001/archpedi.156.6.556
10.1080/09513590.2016.1200552
ContentType Journal Article
Copyright The Author(s) 2020
COPYRIGHT 2020 BioMed Central Ltd.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2020
– notice: COPYRIGHT 2020 BioMed Central Ltd.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
NPM
3V.
7QL
7U9
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
C1K
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
M7N
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12916-020-01516-x
DatabaseName SpringerOpen Free (Free internet resource, activated by CARLI)
CrossRef
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Medical Database (ProQuest)
Algology Mycology and Protozoology Abstracts (Microbiology C)
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database
MEDLINE - Academic




PubMed
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1741-7015
EndPage 16
ExternalDocumentID oai_doaj_org_article_a914f09657ba43e6b00fbbbf619ffd6f
PMC7092491
A618759070
32204714
10_1186_s12916_020_01516_x
Genre Journal Article
GeographicLocations Australia
GeographicLocations_xml – name: Australia
GrantInformation_xml – fundername: National Health and Medical Research Council
  grantid: APP1078444
  funderid: http://dx.doi.org/10.13039/501100000925
– fundername: National Health and Medical Research Council
  grantid: APP1078444
– fundername: ;
  grantid: APP1078444
GroupedDBID ---
0R~
23N
2WC
4.4
53G
5GY
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
IHW
INH
INR
ITC
KQ8
M1P
M48
MK0
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
WOQ
WOW
XSB
AAYXX
ALIPV
CITATION
-5E
-5G
-A0
-BR
3V.
ACRMQ
ADINQ
C24
NPM
PMFND
7QL
7U9
7XB
8FK
AZQEC
C1K
DWQXO
H94
K9.
M7N
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c704t-b858e491781d8c149d438323baad01977070b00590cce319fb1b45b28fa321d93
IEDL.DBID M48
ISSN 1741-7015
IngestDate Wed Aug 27 01:25:57 EDT 2025
Thu Aug 21 18:23:28 EDT 2025
Thu Sep 04 23:47:06 EDT 2025
Fri Jul 25 21:36:41 EDT 2025
Tue Jun 17 21:02:14 EDT 2025
Tue Jun 10 20:46:24 EDT 2025
Thu May 22 21:21:41 EDT 2025
Thu Jan 02 22:58:53 EST 2025
Thu Apr 24 23:09:16 EDT 2025
Tue Jul 01 02:51:24 EDT 2025
Sat Sep 06 07:29:21 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Polycystic ovary syndrome
Treatment
Evidence-based
Diagnosis
Adolescents
Girls
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c704t-b858e491781d8c149d438323baad01977070b00590cce319fb1b45b28fa321d93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-6834-4876
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12916-020-01516-x
PMID 32204714
PQID 2391290958
PQPubID 42775
PageCount 16
ParticipantIDs doaj_primary_oai_doaj_org_article_a914f09657ba43e6b00fbbbf619ffd6f
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7092491
proquest_miscellaneous_2382688808
proquest_journals_2391290958
gale_infotracmisc_A618759070
gale_infotracacademiconefile_A618759070
gale_healthsolutions_A618759070
pubmed_primary_32204714
crossref_primary_10_1186_s12916_020_01516_x
crossref_citationtrail_10_1186_s12916_020_01516_x
springer_journals_10_1186_s12916_020_01516_x
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-03-24
PublicationDateYYYYMMDD 2020-03-24
PublicationDate_xml – month: 03
  year: 2020
  text: 2020-03-24
  day: 24
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC medicine
PublicationTitleAbbrev BMC Med
PublicationTitleAlternate BMC Med
PublicationYear 2020
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References E Bili (1516_CR36) 2014; 179
I Lee (1516_CR84) 2019; 24
LR Harborne (1516_CR105) 2005; 90
S Holbrey (1516_CR115) 2013; 13
MH van Hooff (1516_CR27) 1998; 13
R Hart (1516_CR66) 2010; 94
WA Salameh (1516_CR41) 2014; 101
PJ Adams Hillard (1516_CR29) 2002; 99
SM Slayden (1516_CR45) 2001; 75
SS Lim (1516_CR86) 2013; 14
S Gameiro (1516_CR119) 2019; 2019
RS Legro (1516_CR10) 2013; 98
S Hahn (1516_CR42) 2007; 45
RS Legro (1516_CR28) 2000; 85
M Badouraki (1516_CR62) 2008; 36
SM Veltman-Verhulst (1516_CR75) 2012; 18
H Teede (1516_CR104) 2019; 91
MS Fonhus (1516_CR117) 2018; 9
M Hickey (1516_CR2) 2011; 26
AW Lucky (1516_CR44) 1997; 130
MA Ganie (1516_CR107) 2004; 89
CM DeUgarte (1516_CR49) 2006; 91
L Falsetti (1516_CR106) 1999; 141
M Tartagni (1516_CR108) 2004; 82
HF Allen (1516_CR99) 2005; 18
AS Pena (1516_CR15) 2018; 54
LM Geier (1516_CR94) 2012; 25
A Gambineri (1516_CR52) 2013; 98
K Unluhizarci (1516_CR73) 2012; 42
E Hollinrake (1516_CR76) 2007; 87
HF Escobar-Morreale (1516_CR37) 2001; 145
MH van Hooff (1516_CR31) 2004; 19
R Hart (1516_CR81) 2015; 100
1516_CR19
D Apter (1516_CR25) 1983; 57
N Vermeulen (1516_CR21) 2017
P Villa (1516_CR56) 2013; 78
LJ Moran (1516_CR92) 2011; 7
MM Ollila (1516_CR91) 2016; 101
HJ Teede (1516_CR118) 2018; 209
K Colwell (1516_CR114) 2010; 32
M Gibson-Helm (1516_CR11) 2017; 102
ME Trent (1516_CR74) 2002; 156
M Trent (1516_CR88) 2005; 5
RA Al Khalifah (1516_CR98) 2016; 137
J Boyle (1516_CR113) 2017; 25
SB Christensen (1516_CR3) 2013; 100
AE Treloar (1516_CR22) 1967; 12
AW Lucky (1516_CR53) 2001; 138
Y Chen (1516_CR55) 2008; 21
HA El Maghraby (1516_CR101) 2015; 20
JA Barry (1516_CR78) 2011; 26
1516_CR20
K Hoeger (1516_CR95) 2008; 93
D Ferriman (1516_CR46) 1961; 21
L Casadei (1516_CR63) 2013; 29
AB Sopher (1516_CR67) 2014; 27
D Flug (1516_CR26) 1984; 11
AE Bonny (1516_CR12) 2012; 25
Y Hsia (1516_CR96) 2012; 73
A Gambineri (1516_CR109) 2006; 91
L Li (1516_CR89) 2017; 37
M Gibson-Helm (1516_CR85) 2018; 36
T Lemarchand-Beraud (1516_CR33) 1982; 54
H Teede (1516_CR64) 2019; 30
LF Eichenfield (1516_CR43) 2013; 131
MV Tartagni (1516_CR111) 2014; 27
CA Percy (1516_CR116) 2009; 65
A Tokmak (1516_CR68) 2015; 12
L Ibanez (1516_CR5) 2017; 88
C Villarroel (1516_CR35) 2015; 31
AS Pena (1516_CR34) 2018; 103
E Carmina (1516_CR90) 2012; 119
R Azziz (1516_CR8) 2009; 91
A Dokras (1516_CR82) 2012; 97
HJ Teede (1516_CR6) 2018; 33
A Yetim (1516_CR69) 2016; 8
World Health Organization (1516_CR102) 2016
A Dokras (1516_CR77) 2011; 117
SL Kristensen (1516_CR57) 2010; 25
D Apter (1516_CR24) 1977; 45
X Zhao (1516_CR50) 2011; 96
LG Cooney (1516_CR79) 2017; 19
M Razzaghy-Azar (1516_CR60) 2011; 39
HJ Teede (1516_CR9) 2011; 195
JY Kim (1516_CR70) 2017; 60
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (1516_CR7) 2004; 81
H Al-Zubeidi (1516_CR100) 2015; 28
M Amiri (1516_CR110) 2014; 15
L Ibanez (1516_CR97) 2004; 89
TW Kelsey (1516_CR59) 2013; 8
KA Martin (1516_CR112) 2008; 93
ES Knochenhauer (1516_CR48) 1998; 83
MR Sebastian (1516_CR14) 2018; 31
LD Herter (1516_CR61) 2002; 178
G Bozdag (1516_CR1) 2016; 31
E Codner (1516_CR58) 2011; 95
National Health and Medical Research Council (1516_CR18) 2009
M de Bastos (1516_CR103) 2014; 3
WL Miller (1516_CR71) 2011; 32
MH van Hooff (1516_CR51) 1999; 14
GL Jones (1516_CR54) 2008; 14
CE Cesta (1516_CR80) 2016; 73
JP Domecq (1516_CR93) 2013; 98
A Diaz (1516_CR32) 2006; 118
BO Yildiz (1516_CR47) 2010; 16
MC Brouwers (1516_CR16) 2010; 182
National Health and Medical Research Council (1516_CR17) 2007
LG Cooney (1516_CR83) 2017; 32
PW Speiser (1516_CR72) 2010; 95
E Stener-Victorin (1516_CR40) 2010; 95
P Koskinen (1516_CR38) 1996; 65
S Iliodromiti (1516_CR65) 2013; 98
O Widholm (1516_CR23) 1971; 14
E Rudnicka (1516_CR39) 2016; 32
SF Witchel (1516_CR4) 2015; 83
GB Slap (1516_CR30) 2003; 17
B Auble (1516_CR13) 2013; 26
EP Thong (1516_CR87) 2020; 8
References_xml – volume: 75
  start-page: 889
  issue: 5
  year: 2001
  ident: 1516_CR45
  publication-title: Fertil Steril
  doi: 10.1016/S0015-0282(01)01701-0
– volume: 65
  start-page: 517
  issue: 3
  year: 1996
  ident: 1516_CR38
  publication-title: Fertil Steril
  doi: 10.1016/S0015-0282(16)58146-1
– volume: 45
  start-page: 202
  issue: 2
  year: 2007
  ident: 1516_CR42
  publication-title: Clin Chem Lab Med
  doi: 10.1515/CCLM.2007.031
– volume: 54
  start-page: 351
  issue: 4
  year: 2018
  ident: 1516_CR15
  publication-title: J Paediatr Child Health
  doi: 10.1111/jpc.13821
– volume: 73
  start-page: 196
  year: 2016
  ident: 1516_CR80
  publication-title: Psychoneuroendocrinology.
  doi: 10.1016/j.psyneuen.2016.08.005
– volume: 91
  start-page: 456
  issue: 2
  year: 2009
  ident: 1516_CR8
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2008.06.035
– volume: 137
  start-page: e20154089
  issue: 5
  year: 2016
  ident: 1516_CR98
  publication-title: Pediatrics.
  doi: 10.1542/peds.2015-4089
– volume: 103
  start-page: 235
  issue: 3
  year: 2018
  ident: 1516_CR34
  publication-title: Arch Dis Childhood
  doi: 10.1136/archdischild-2017-312968
– volume: 101
  start-page: 1135
  issue: 4
  year: 2014
  ident: 1516_CR41
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2013.12.056
– volume: 16
  start-page: 51
  issue: 1
  year: 2010
  ident: 1516_CR47
  publication-title: Hum Reprod Update
  doi: 10.1093/humupd/dmp024
– volume: 100
  start-page: 470
  issue: 2
  year: 2013
  ident: 1516_CR3
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2013.04.001
– volume: 30
  start-page: 467
  issue: 7
  year: 2019
  ident: 1516_CR64
  publication-title: Trends Endocrinol Metab
  doi: 10.1016/j.tem.2019.04.006
– volume: 37
  start-page: 1036
  issue: 8
  year: 2017
  ident: 1516_CR89
  publication-title: J Obstet Gynaecol
  doi: 10.1080/01443615.2017.1318840
– volume: 19
  start-page: 383
  issue: 2
  year: 2004
  ident: 1516_CR31
  publication-title: Hum Reprod
  doi: 10.1093/humrep/deh079
– volume: 131
  start-page: S163
  issue: Suppl. 3
  year: 2013
  ident: 1516_CR43
  publication-title: Pediatrics.
  doi: 10.1542/peds.2013-0490B
– volume: 57
  start-page: 82
  issue: 1
  year: 1983
  ident: 1516_CR25
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem-57-1-82
– volume: 65
  start-page: 2046
  issue: 10
  year: 2009
  ident: 1516_CR116
  publication-title: J Adv Nurs
  doi: 10.1111/j.1365-2648.2009.05061.x
– volume: 98
  start-page: 4655
  issue: 12
  year: 2013
  ident: 1516_CR93
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2013-2385
– volume: 25
  start-page: 259
  issue: 4
  year: 2012
  ident: 1516_CR12
  publication-title: J Pediatr Adolesc Gynecol
  doi: 10.1016/j.jpag.2012.03.004
– volume: 195
  start-page: S65
  issue: 6
  year: 2011
  ident: 1516_CR9
  publication-title: Med J Aust
– volume: 89
  start-page: 1592
  issue: 4
  year: 2004
  ident: 1516_CR97
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2003-031281
– volume: 31
  start-page: 625
  issue: 8
  year: 2015
  ident: 1516_CR35
  publication-title: Gynecol Endocrinol
  doi: 10.3109/09513590.2015.1025380
– volume: 8
  start-page: 288
  issue: 3
  year: 2016
  ident: 1516_CR69
  publication-title: J Clin Res Pediatr Endocrinol
  doi: 10.4274/jcrpe.3253
– volume: 19
  start-page: 83
  issue: 11
  year: 2017
  ident: 1516_CR79
  publication-title: Curr Psychiatry Rep
  doi: 10.1007/s11920-017-0834-2
– volume: 13
  start-page: 51
  year: 2013
  ident: 1516_CR115
  publication-title: BMC Womens Health
  doi: 10.1186/1472-6874-13-51
– volume: 85
  start-page: 1021
  issue: 3
  year: 2000
  ident: 1516_CR28
  publication-title: J Clin Endocrinol Metab
– volume: 101
  start-page: 739
  issue: 2
  year: 2016
  ident: 1516_CR91
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2015-3543
– volume: 89
  start-page: 2756
  issue: 6
  year: 2004
  ident: 1516_CR107
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2003-031780
– volume: 14
  start-page: 15
  issue: 1
  year: 2008
  ident: 1516_CR54
  publication-title: Hum Reprod Update
  doi: 10.1093/humupd/dmm030
– volume: 5
  start-page: 107
  issue: 2
  year: 2005
  ident: 1516_CR88
  publication-title: Ambul Pediatr
  doi: 10.1367/A04-130R.1
– volume: 81
  start-page: 19
  issue: 1
  year: 2004
  ident: 1516_CR7
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2003.10.004
– volume: 14
  start-page: 11
  issue: Suppl 14
  year: 1971
  ident: 1516_CR23
  publication-title: Acta Obstet Gynecol Scand Suppl
– volume-title: NHMRC Standards and Procedures for Externally Developed Guidelines
  year: 2007
  ident: 1516_CR17
– volume: 26
  start-page: 2442
  issue: 9
  year: 2011
  ident: 1516_CR78
  publication-title: Hum Reprod
  doi: 10.1093/humrep/der197
– volume: 28
  start-page: 853
  issue: 7–8
  year: 2015
  ident: 1516_CR100
  publication-title: J Pediatr Endocrinol Metab
– volume: 21
  start-page: 347
  issue: 6
  year: 2008
  ident: 1516_CR55
  publication-title: J Pediatr Adolesc Gynecol
  doi: 10.1016/j.jpag.2008.01.081
– volume: 138
  start-page: 134
  issue: 1
  year: 2001
  ident: 1516_CR53
  publication-title: J Pediatr
  doi: 10.1067/mpd.2001.109790
– volume: 13
  start-page: 2252
  issue: 8
  year: 1998
  ident: 1516_CR27
  publication-title: Hum Reprod
  doi: 10.1093/humrep/13.8.2252
– volume: 29
  start-page: 545
  issue: 6
  year: 2013
  ident: 1516_CR63
  publication-title: Gynecol Endocrinol
  doi: 10.3109/09513590.2013.777415
– volume: 25
  start-page: 367
  issue: 6
  year: 2012
  ident: 1516_CR94
  publication-title: J Pediatr Adolesc Gynecol
  doi: 10.1016/j.jpag.2012.06.008
– volume: 3
  start-page: CD010813
  year: 2014
  ident: 1516_CR103
  publication-title: Cochrane Database Syst Rev
– volume: 39
  start-page: 64
  issue: 2
  year: 2011
  ident: 1516_CR60
  publication-title: J Clin Ultrasound
  doi: 10.1002/jcu.20723
– volume: 117
  start-page: 145
  issue: 1
  year: 2011
  ident: 1516_CR77
  publication-title: Obstet Gynecol
  doi: 10.1097/AOG.0b013e318202b0a4
– volume: 98
  start-page: 1641
  issue: 4
  year: 2013
  ident: 1516_CR52
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2012-3537
– volume: 12
  start-page: 77
  issue: 1 Pt 2
  year: 1967
  ident: 1516_CR22
  publication-title: Int J Fertil
– volume: 118
  start-page: 2245
  issue: 5
  year: 2006
  ident: 1516_CR32
  publication-title: Pediatrics.
  doi: 10.1542/peds.2006-2481
– volume: 11
  start-page: 495
  issue: 6
  year: 1984
  ident: 1516_CR26
  publication-title: Ann Hum Biol
  doi: 10.1080/03014468400007411
– volume: 24
  start-page: 787
  issue: 5
  year: 2019
  ident: 1516_CR84
  publication-title: Eat Weight Disord
  doi: 10.1007/s40519-018-0533-y
– volume: 91
  start-page: 479
  issue: 4
  year: 2019
  ident: 1516_CR104
  publication-title: Clin Endocrinol
  doi: 10.1111/cen.14013
– volume: 98
  start-page: 3332
  issue: 8
  year: 2013
  ident: 1516_CR65
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2013-1393
– volume: 178
  start-page: 1531
  issue: 6
  year: 2002
  ident: 1516_CR61
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/ajr.178.6.1781531
– volume: 95
  start-page: 810
  issue: 2
  year: 2010
  ident: 1516_CR40
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2009-1908
– volume: 82
  start-page: 752
  issue: 3
  year: 2004
  ident: 1516_CR108
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2004.02.118
– volume: 102
  start-page: 604
  issue: 2
  year: 2017
  ident: 1516_CR11
  publication-title: J Clin Endocrinol Metab
– volume: 26
  start-page: 234
  issue: 4
  year: 2013
  ident: 1516_CR13
  publication-title: J Pediatr Adolesc Gynecol
  doi: 10.1016/j.jpag.2013.03.007
– volume: 15
  start-page: 205
  issue: 4
  year: 2014
  ident: 1516_CR110
  publication-title: J Reprod Infertil
– volume: 36
  start-page: 35
  year: 2018
  ident: 1516_CR85
  publication-title: Semin Reprod Med
  doi: 10.1055/s-0038-1667155
– volume: 8
  start-page: e71465
  issue: 9
  year: 2013
  ident: 1516_CR59
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0071465
– volume: 18
  start-page: 761
  issue: 8
  year: 2005
  ident: 1516_CR99
  publication-title: J Pediatr Endocrinol Metab
  doi: 10.1515/JPEM.2005.18.8.761
– volume: 119
  start-page: 263
  issue: 2 Pt 1
  year: 2012
  ident: 1516_CR90
  publication-title: Obstet Gynecol
  doi: 10.1097/AOG.0b013e31823f7135
– volume-title: Quick reference chart for the WHO medical eligibility criteria for contraceptive use
  year: 2016
  ident: 1516_CR102
– volume: 93
  start-page: 1105
  issue: 4
  year: 2008
  ident: 1516_CR112
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2007-2437
– ident: 1516_CR20
– volume: 95
  start-page: 4133
  issue: 9
  year: 2010
  ident: 1516_CR72
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2009-2631
– volume: 99
  start-page: 655
  issue: 4
  year: 2002
  ident: 1516_CR29
  publication-title: Obstet Gynecol
  doi: 10.1016/S0029-7844(02)01660-5
– volume: 60
  start-page: 333
  issue: 3
  year: 2017
  ident: 1516_CR70
  publication-title: J Adolesc Health
  doi: 10.1016/j.jadohealth.2016.10.015
– volume: 94
  start-page: 1118
  issue: 3
  year: 2010
  ident: 1516_CR66
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2009.11.002
– volume: 73
  start-page: 135
  issue: 1
  year: 2012
  ident: 1516_CR96
  publication-title: Br J Clin Pharmacol
  doi: 10.1111/j.1365-2125.2011.04063.x
– volume: 88
  start-page: 371
  issue: 6
  year: 2017
  ident: 1516_CR5
  publication-title: Hormone Res Paed
  doi: 10.1159/000479371
– volume: 100
  start-page: 911
  issue: 3
  year: 2015
  ident: 1516_CR81
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2014-3886
– volume-title: NHMRC Levels of Evidence and Grades for Recommendations for Developers of Guidelines
  year: 2009
  ident: 1516_CR18
– volume: 91
  start-page: 3970
  issue: 10
  year: 2006
  ident: 1516_CR109
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2005-2250
– volume: 25
  start-page: 175
  issue: 3
  year: 2017
  ident: 1516_CR113
  publication-title: Aust J Rural Health
  doi: 10.1111/ajr.12288
– volume: 87
  start-page: 1369
  issue: 6
  year: 2007
  ident: 1516_CR76
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2006.11.039
– ident: 1516_CR19
– volume: 95
  start-page: 702
  issue: 2
  year: 2011
  ident: 1516_CR58
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2010.06.015
– volume: 42
  start-page: 86
  issue: 1
  year: 2012
  ident: 1516_CR73
  publication-title: Eur J Clin Investig
  doi: 10.1111/j.1365-2362.2011.02550.x
– volume: 32
  start-page: 81
  issue: 1
  year: 2011
  ident: 1516_CR71
  publication-title: Endocrine Rev
  doi: 10.1210/er.2010-0013
– volume: 7
  start-page: CD007506
  year: 2011
  ident: 1516_CR92
  publication-title: Cochrane Database Syst Rev
– volume: 179
  start-page: 32
  year: 2014
  ident: 1516_CR36
  publication-title: Eur J Obst Gynecol Reprod Biol
  doi: 10.1016/j.ejogrb.2014.05.006
– volume: 90
  start-page: 4593
  issue: 8
  year: 2005
  ident: 1516_CR105
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2004-2283
– volume: 96
  start-page: 792
  issue: 3
  year: 2011
  ident: 1516_CR50
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2011.06.040
– volume: 9
  start-page: CD012472
  year: 2018
  ident: 1516_CR117
  publication-title: Cochrane Database Syst Rev
– volume: 93
  start-page: 4299
  issue: 11
  year: 2008
  ident: 1516_CR95
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2008-0461
– volume: 8
  start-page: 134
  year: 2020
  ident: 1516_CR87
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(19)30345-6
– volume: 45
  start-page: 1039
  issue: 5
  year: 1977
  ident: 1516_CR24
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem-45-5-1039
– volume: 209
  start-page: S3
  issue: 7
  year: 2018
  ident: 1516_CR118
  publication-title: Med J Aust
– volume: 145
  start-page: 619
  issue: 5
  year: 2001
  ident: 1516_CR37
  publication-title: Eur J Endocrinol
  doi: 10.1530/eje.0.1450619
– volume: 83
  start-page: 3078
  issue: 9
  year: 1998
  ident: 1516_CR48
  publication-title: J Clin Endocrinol Metab
– volume: 54
  start-page: 241
  issue: 2
  year: 1982
  ident: 1516_CR33
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem-54-2-241
– volume: 14
  start-page: 2223
  issue: 9
  year: 1999
  ident: 1516_CR51
  publication-title: Hum Reprod
  doi: 10.1093/humrep/14.9.2223
– volume: 18
  start-page: 638
  issue: 6
  year: 2012
  ident: 1516_CR75
  publication-title: Hum Reprod Update
  doi: 10.1093/humupd/dms029
– volume: 27
  start-page: 161
  issue: 3
  year: 2014
  ident: 1516_CR111
  publication-title: J Pediatr Adolesc Gynecol
  doi: 10.1016/j.jpag.2013.09.010
– volume: 78
  start-page: 285
  issue: 2
  year: 2013
  ident: 1516_CR56
  publication-title: Clin Endocrinol
  doi: 10.1111/j.1365-2265.2012.04475.x
– volume: 141
  start-page: 361
  issue: 4
  year: 1999
  ident: 1516_CR106
  publication-title: Eur J Endocrinol
  doi: 10.1530/eje.0.1410361
– volume: 31
  start-page: 367
  issue: 4
  year: 2018
  ident: 1516_CR14
  publication-title: J Pediatr Adolesc Gynecol
  doi: 10.1016/j.jpag.2018.01.007
– volume: 12
  start-page: 199
  issue: 4
  year: 2015
  ident: 1516_CR68
  publication-title: Turk J Obstet Gynecol
  doi: 10.4274/tjod.21549
– volume: 14
  start-page: 95
  issue: 2
  year: 2013
  ident: 1516_CR86
  publication-title: Obes Rev
  doi: 10.1111/j.1467-789X.2012.01053.x
– volume-title: Manual for ESHRE guideline development
  year: 2017
  ident: 1516_CR21
– volume: 91
  start-page: 1345
  issue: 4
  year: 2006
  ident: 1516_CR49
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2004-2301
– volume: 20
  start-page: 131
  issue: 3
  year: 2015
  ident: 1516_CR101
  publication-title: Middle East Fertil Soc J
  doi: 10.1016/j.mefs.2014.10.003
– volume: 31
  start-page: 2841
  issue: 12
  year: 2016
  ident: 1516_CR1
  publication-title: Hum Reprod
  doi: 10.1093/humrep/dew218
– volume: 33
  start-page: 1602
  issue: 9
  year: 2018
  ident: 1516_CR6
  publication-title: Hum Reprod
  doi: 10.1093/humrep/dey256
– volume: 32
  start-page: 1075
  issue: 5
  year: 2017
  ident: 1516_CR83
  publication-title: Hum Reprod
  doi: 10.1093/humrep/dex044
– volume: 21
  start-page: 1440
  year: 1961
  ident: 1516_CR46
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem-21-11-1440
– volume: 27
  start-page: 1175
  issue: 11–12
  year: 2014
  ident: 1516_CR67
  publication-title: J Pediatr Endocrinol Metab
– volume: 98
  start-page: 4565
  issue: 12
  year: 2013
  ident: 1516_CR10
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2013-2350
– volume: 32
  start-page: 453
  issue: 5
  year: 2010
  ident: 1516_CR114
  publication-title: J Obstet Gynaecol Can
  doi: 10.1016/S1701-2163(16)34499-1
– volume: 83
  start-page: 376
  year: 2015
  ident: 1516_CR4
  publication-title: Hormone Res Paed.
  doi: 10.1159/000375530
– volume: 182
  start-page: E839
  issue: 18
  year: 2010
  ident: 1516_CR16
  publication-title: CMAJ.
  doi: 10.1503/cmaj.090449
– volume: 2019
  start-page: hoz011
  issue: 3
  year: 2019
  ident: 1516_CR119
  publication-title: Hum Reprod Open
  doi: 10.1093/hropen/hoz011
– volume: 130
  start-page: 30
  issue: 1
  year: 1997
  ident: 1516_CR44
  publication-title: J Pediatr
  doi: 10.1016/S0022-3476(97)70307-X
– volume: 25
  start-page: 3117
  issue: 12
  year: 2010
  ident: 1516_CR57
  publication-title: Hum Reprod
  doi: 10.1093/humrep/deq273
– volume: 97
  start-page: 225
  issue: 1
  year: 2012
  ident: 1516_CR82
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2011.10.022
– volume: 26
  start-page: 1469
  issue: 6
  year: 2011
  ident: 1516_CR2
  publication-title: Hum Reprod
  doi: 10.1093/humrep/der102
– volume: 17
  start-page: 75
  issue: 1
  year: 2003
  ident: 1516_CR30
  publication-title: Best Pract Res Clin Obstet Gynaecol
  doi: 10.1053/ybeog.2002.0342
– volume: 36
  start-page: 539
  issue: 9
  year: 2008
  ident: 1516_CR62
  publication-title: J Clin Ultrasound
  doi: 10.1002/jcu.20522
– volume: 156
  start-page: 556
  issue: 6
  year: 2002
  ident: 1516_CR74
  publication-title: Arch Pediatr Adolesc Med
  doi: 10.1001/archpedi.156.6.556
– volume: 32
  start-page: 931
  issue: 11
  year: 2016
  ident: 1516_CR39
  publication-title: Gynecol Endocrinol
  doi: 10.1080/09513590.2016.1200552
SSID ssj0025774
Score 2.6275897
Snippet Background Diagnosing polycystic ovary syndrome (PCOS) during adolescence is challenging because features of normal pubertal development overlap with adult...
Diagnosing polycystic ovary syndrome (PCOS) during adolescence is challenging because features of normal pubertal development overlap with adult diagnostic...
Background Diagnosing polycystic ovary syndrome (PCOS) during adolescence is challenging because features of normal pubertal development overlap with adult...
Abstract Background Diagnosing polycystic ovary syndrome (PCOS) during adolescence is challenging because features of normal pubertal development overlap with...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 72
SubjectTerms Acne
Adolescence
Adolescents
Age
Amenorrhea
Antidiabetics
Biomedicine
Child development
Consumers
Contraceptives
Criteria
Demographic aspects
Depression (Mood disorder)
Diagnosis
Diagnostic systems
Eating disorders
Endocrinology
Evaluation
Evidence-based
Evidence-based medicine
Experts
Girls
Guideline
Gynecology
Health care reform
Health services
Hirsutism
Hormones
Infertility
Medical diagnosis
Medical personnel
Medicine
Medicine & Public Health
Menarche
Menstrual cycle
Menstruation
Metformin
Physiology
Polycystic ovary syndrome
Practice guidelines (Medicine)
Puberty
Quality
Retirement benefits
Symptom management
Teenagers
Treatment
Ultrasound
Womens health
Youth
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLgpZHSluMhMQBoiaOYzvHpaKqkMqJSj0gWbZjQ6Uqqdpd1P33zDhO2BRBL9xW8SSbzHuS8TeEvPWhUd4GkACUPDkvLU4DtDK3RraCBe9Y7M05_SJOzvjn8_p8Y9QX9oQN8MAD4w5NU_KAECXSGl55AWoSrLUBEv8QWhHQ-xZNMRZTqdSqIasZt8gocXgDUa3EZltswqrh1-0sDEW0_j998kZQutsweeeraQxGx0_I45RF0sVw90_JA99tk4en6Tv5Dvm2mICa6FV_uXZrhGOm_U9zvaYjSAE1DktP-AO67CkkgvRi8_Ug9WngaI6RrqXfV4iIBZd_Rs6OP309OsnTHIXcyYIvc6tq5TnUZZCbKgclUYv4pKyyxrSQ4UkJZm_jLlTnPJhksKXltWUqmIqVbVM9J1td3_mXhEIyVRjHW8cLxY2ojFDeyFA55tEbhIyUI1u1SyDjOOviUsdiQwk9iEKDKHQUhb7NyPvpnKsBYuOf1B9RWhMlwmPHA6A0OimNvk9pMvIaZa2HvaaTkeuFKKF-a4AfGXkXKdDM4QGcSbsVgA0ImDWj3JtRgnm6-fKoTzq5hxvNqgbf_zW1ysibaRnPxJa3zvcrpIHKT4F7BZoXg_pNDw1euICsgmdEzhRzxpX5SnfxI4KHywIr7jIjH0YV_n1bf-f67v_g-ivyiEUTrHLG98jW8nrl9yGlW9qDaL2_AHaESFA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4k1KASMhcYCoiePEzgktiKpCKicq7QHJsh27VKqSZR9V998z4zjZpojeonjy8IxnPGOPvyHkvfO1dMaDBCDkSXlusBqgEanRoqmYd5aF3JyTH9XxKf8-L-dxwW0V0yoHmxgMddNZXCM_ZEWNSyZ1KT8v_qRYNQp3V2MJjbvkXg6eCJZuEPNdwFWCbzMclJHV4QpekGPKLaZilXB1NZmMAmb_v5b52tR0M23yxt5pmJKOHpGH0Zeks174j8kd1z4h90_ibvlT8ms2wjXRRXextVsEZabdpV5u6QBVQLXFABQ-QNcdBXeQnl9fJKQulh1Ncb5r6NkGcbHg9c_I6dG3n1-P01hNIbUi4-vUyFI6DtEZeKjSQmDUIEopK4zWDfh5QoDym3AW1VoHiulNbnhpmPS6YHlTF8_JXtu17iWh4FJl2vLG8kxyXRW6kk4LX1jm0Cb4hOQDW5WNUONY8eJChZBDVqoXhQJRqCAKdZWQj-Mzix5o41bqLyitkRJBssONbnmmos4pXefcI7qNMJoXroLeeWOMh5jR-6aC33yLslb9idNR1dWsyiGKq4EfCfkQKFDZoQNWxzMLwAaEzZpQHkwoQUnttHkYTyoaiZXaDemEvBub8UlMfGtdt0EaiP8kGFmgedEPv7HTYIsz8C14QsRkYE64Mm1pz38HCHGRYdydJ-TTMIR3v_V_ru_f3otX5AELylWkjB-QvfVy416Dy7Y2b4Je_gUaxz6Y
  priority: 102
  providerName: ProQuest
– databaseName: SpringerOpen Free (Free internet resource, activated by CARLI)
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3daxQxEA9SQXwRrV9bq40g-KCLu9lskn08j5Yi1CcLfRBCkk20UHZLeyfef-9MNrve1g_o23GZ3G3mKzObmV8IeeNDo7wNIAFIeXJeWrwN0MrcGtkKFrxjsTbn5LM4PuWfzuqzBJODvTDb5_elEh-uYT8qsUwWy6dq-ATx4t0aHC9q81Isp-SqhjhmbIr567zZxhPx-f_0wlvb0M0SyRvnpHH7OXpIHqS4kS4GQT8id3y3S-6dpJPxx-TrYoJmopf9xcZtEICZ9j_M1YaOsATUOEw24Q_oqqcQ-tHz7ReC1KcrRnPc21r6bY0YWPDzT8jp0eGX5XGebk7InSz4KreqVp5DJgbRqHKQBLWISMoqa0wLMZ2UYOg29p0658EIgy0try1TwVSsbJvqKdnp-s4_JxTCp8I43jpeKG5EZYTyRobKMY_2HzJSjmzVLsGK4-0WFzqmF0roQRQaRKGjKPTPjLyb5lwOoBr_pf6I0pooERA7fgF6opN9adOUPCCSjbSGV17A6oK1NkB-GEIr4DEPUNZ66C6dzFovRAkZWwP8yMjbSIGGDQtwJvUnABsQImtGuT-jBIN08-FRn3RyCNeaVQ2-8WtqlZHX0zDOxCK3zvdrpIFcT4FDBZpng_pNiwa_W0AcwTMiZ4o548p8pDv_HuHCZYE5dpmR96MK_36sf3N973bkL8h9Fo2tyhnfJzurq7V_CeHayr6KdvoLZes34w
  priority: 102
  providerName: Springer Nature
Title Adolescent polycystic ovary syndrome according to the international evidence-based guideline
URI https://link.springer.com/article/10.1186/s12916-020-01516-x
https://www.ncbi.nlm.nih.gov/pubmed/32204714
https://www.proquest.com/docview/2391290958
https://www.proquest.com/docview/2382688808
https://pubmed.ncbi.nlm.nih.gov/PMC7092491
https://doaj.org/article/a914f09657ba43e6b00fbbbf619ffd6f
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3daxQxEA-1BfFF_Ha1nhEEH3TtfmQ32QeRu6OlCC1SPDhECEk2qYVjt17vpPffO5P9sFurT74cd5fJ3WY-kplk8htCXltXCKsdSABCnpDFGqsBah5qxcs8cdYkPjfn6Dg_nLFP82y-RbpyRy0DL24M7bCe1Gy5eH_5Y_MRDP6DN3iR713AmhVjKi2mWGXwDnzKHX9ehKl8rD9VAO3krLs4c2O_weLkMfz_nKmvLFXX0yivnaX6JergHrnb-pZ03CjDfbJlqwfk9lF7ev6QfBv38E30vF5szAZBmmn9Uy03tIMuoMpgQAp_QFc1BfeQnl3dNKS2LUMa4vpX0tM14mTBzz8is4P9L9PDsK2uEBoesVWoRSYsg2gNPFZhIFAqEbU0SbVSJfh9nMNkoP3dVGMsGKrTsWaZToRTaRKXRfqYbFd1ZZ8SCi5WpAwrDYsEU3mqcmEVd6lJLM4RLiBxx1ZpWuhxrICxkD4EEblsRCFBFNKLQl4G5G3f57wB3vgn9QSl1VMiaLb_ol6eytYGpSpi5hDthmvFUpvD6JzW2kEM6VyZw2O-RFnL5gZqb_pynMcQ1RXAj4C88RSojjAAo9o7DMAGhNEaUO4OKMFozbC50yfZ6bxM0gJ3BYtMBORV34w9MRGusvUaaSAeFDDpAs2TRv36QcPcHIGvwQLCB4o54MqwpTr77iHFeYRxeByQd50K_36sv3P92f_g-nNyJ_EmmIYJ2yXbq-XavgBHb6VH5Baf8xHZmewffz6BT9N8OvKbJiNv1_B6Mvn6Czo9VPg
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIgEXxJtAoUYCcYCoieMkzgGh5VFtabenVtoDkrEdu1SqNss-oPun-I3MOI9tiuitt9VmsmvPyzP2-BtCXllXCKsdSABSnpDHGrsB6jzUKi8z5qxhvjZndJgNj_nXcTreIH_auzBYVtn6RO-oy8rgHvkOSwrcMilS8WH6M8SuUXi62rbQqNVi365-Q8o2f7_3GeT7mrHdL0efhmHTVSA0ecQXoRapsByyFIjUhIEEoUS0TpZopUqId_IcjED7O5nGWFBQp2PNU82EUwmLSwRfApd_g-MRI9hPPl4neCnEUu3FHJHtzGHAMZb4YulXCp_Oe4uf7xHw70pwYSm8XKZ56azWL4G7d8mdJnalg1rZ7pENO7lPbo6a0_kH5Nugg4ei0-psZVYIAk2rX2q2oi00AlUGE174A7qoKISf9PTipiS1TZvTENfXkp4sEYcLfv4hOb4WPj8im5NqYp8QCiFcpAwvDY8EV1miMmFV7hLDLPogF5C4Zas0DbQ5dtg4kz7FEZmsRSFBFNKLQp4H5G33zrQG9riS-iNKq6NEUG7_RTU7kY2NS1XE3CGaTq4VT2wGs3Naawc5qnNlBsPcRlnL-oZr51rkIIshayyAHwF54ynQucAEjGruSAAbEKarR7nVowSnYPqPW32SjVOay7UJBeRl9xjfxEK7ia2WSAP5pgCnDjSPa_XrJg2-P4JYhgck7ylmjyv9J5PTHx6yPI8wz48D8q5V4fWw_s_1p1fPYpvcGh6NDuTB3uH-M3KbeUNLQsa3yOZitrTPIVxc6BfeRin5ft1O4S9blXmt
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEBYlgdBLafp0mzYqFHpoTfyQbfnoPpZ024RCG8ihICRZSgLBXjbekv33nZFld50-oLdlNdq1NJrRfNbMJ0JeGltyoyxoACBPyGKFtwGqIlSyqPPEGp243Jyj4_zwhM1Ps9ONKn6X7T4cSfY1DcjS1HQHi9r2Js7zgyvYpWJMnsWkqgw-QRS5zbOyBPi1XVXzr_MRdGUQ3wzFMn_sOdmQHG__7955Y3u6mTp54_zUbUuzu-SOjydp1S-AXXLLNPfIzpE_Mb9PvlcjZRNdtJdrvUZiZtr-kMs1HegKqNQIQuEPaNdSCAnpxeaLQmr81aMh7nk1PVshNxb8_ANyMvvw7d1h6G9UCHURsS5UPOOGAUKDKJVrAEc1MpUmqZKyhlivKMABKFePqrUB47QqVixTCbcyTeK6TB-SraZtzGNCIayKpGa1ZhFnMk9lzo0sbKoTg37BBiQeplVoTzeOt15cCgc7eC56VQhQhXCqENcBeT32WfRkG_-UfovaGiWRKNt90S7PhLc7IcuYWWS4KZRkqclhdFYpZQE3Wlvn8Jj7qGvRV52O5i6qPAYkV8J8BOSVk0CDhwFo6esWYBqQOmsiuTeRBEPV0-ZhPQnvKK5Ekpb4JrDMeEBejM3YE5PfGtOuUAYwIAdHCzKP-uU3Dhr8cQTxBQtIMVmYk1mZtjQX545GvIgQe8cBeTMs4V-P9fdZf_J_4vtk58v7mfj88fjTU3I7cXaXhgnbI1vdcmWeQUTXqefeaH8CAfNEkA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adolescent+polycystic+ovary+syndrome+according+to+the+international+evidence-based+guideline&rft.jtitle=BMC+medicine&rft.au=Alexia+S.+Pe%C3%B1a&rft.au=Selma+F.+Witchel&rft.au=Kathleen+M.+Hoeger&rft.au=Sharon+E.+Oberfield&rft.date=2020-03-24&rft.pub=BMC&rft.eissn=1741-7015&rft.volume=18&rft.issue=1&rft.spage=1&rft.epage=16&rft_id=info:doi/10.1186%2Fs12916-020-01516-x&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_a914f09657ba43e6b00fbbbf619ffd6f
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1741-7015&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1741-7015&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1741-7015&client=summon